Cannabichromene
CBC
A minor non-intoxicating cannabinoid with interesting preclinical anti-inflammatory activity and essentially no human data.
Preclinical onlyNon-intoxicating
Evidence status
In-vitro and animal work only.
CBC does not bind CB1 strongly, which is consistent with its lack of intoxicating effect. Preclinical interest centres on TRP channel activity and anti-inflammatory effects.
It appears in most full-spectrum products at low concentrations. There is no reliable basis for selecting a product on CBC content.
Commonly used for
- • Present in full-spectrum products; not a reason to choose one
Cautions
- • No meaningful human evidence base.